Check-Cap Ltd
CHEK
Market Cap$10.7M
Close$
$0.55
75.6% downside
Current Fair Value
75.6% downsideOvervalued by 75.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.70 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | 0.0 |
| Outstanding Shares | 5,846,989 |
| Avg 30 Day Volume | 65,391 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
ESG Score
No data
About Check-Cap Ltd
65 employees
CEO: Guy Neev Check-Cap is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) preventionthrough the introduction of C-Scan®, thefirst and onlypatient-friendly preparation-freescreening test to detect polypsbeforeth...